Impact of appropriate empirical antibiotics on clinical outcomes in Klebsiella pneumoniae bacteraemia

被引:3
|
作者
Man, M. Y. [1 ]
Shum, H. P. [1 ]
Li, K. C. [1 ]
Yan, W. W. [1 ]
机构
[1] Pamela Youde Nethersole Eastern Hosp, Dept Intens Care, Hong Kong, Peoples R China
关键词
ANTIMICROBIAL THERAPY; SOFA SCORE; SEPSIS; RESISTANCE; MORTALITY; CARE;
D O I
10.12809/hkmj208698
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Klebsiella pneumoniae infections can cause septic shock, multiorgan failure, and death. Methods: This retrospective cohort study included adults with K pneumoniae bacteraemia treated from 1 January 2009 to 30 June 2017. Demographics, microbiology, and outcomes were analysed. The primary outcome was 90-day all-cause mortality; secondary outcomes were intensive care unit (ICU) and hospital mortalities, ICU and hospital lengths of stay, and ICU ventilator duration. Results: In total, 984 patients had K pneumoniae bacteraemia; of them, 686 received appropriate empirical antibiotics. Overall, 205 patients required intensive care. Older age (odds ratio [OR]=1.60; 95% confidence interval [CI]=1.120-2.295; P=0.010), chronic kidney disease (OR=1.81; 95% CI=1.181-2.785; P=0.007), mechanical ventilation (OR=1.79; 95% CI=1.188-2.681; P=0.005), pneumonia (OR=1.50; 95% CI=1.030-2.187; P=0.034), and carbapenem-resistant or extended-spectrum beta-lactamase (ESBL)-producing isolates (OR=12.51; 95% CI=7.886-19.487; P<0.001) were associated with greater risk of inappropriate empirical treatment. Ninety-day mortality was significantly higher among patients with inappropriate empirical treatment; independent predictors included pneumonia (hazard ratio [HR]=2.94; 95% CI=2.271-3.808; P<0.001), gastrointestinal infection (HR=2.77; 95% CI=2.055-3.744; P<0.001), failed empirical antibiotics (HR=2.45; 95% CI=1.928-3.124; P<0.001), older age (HR=1.79; 95% CI=1.356-2.371; P<0.001), solid tumour (HR=1.77; 95% CI=1.401-2.231; P<0.001), carbapenem-resistant or ESBL-producing isolates (HR=1.64; 95% CI=1.170-2.297; P=0.004), patients admitted through the Department of Medicine (HR=1.39; 95% CI=1.076-1.800; P=0.012), and higher total Sequential Organ Failure Assessment score (HR=1.09; 95% CI=1.058-1.112; P=0.023). Among ICU patients, inappropriate empirical antibiotic treatment was significantly associated with increased ventilator duration and 90-day mortality. Conclusions: Klebsiella pneumoniae bacteraemia was associated with high 90-day and ICU mortalities; 90-day mortality increased with inappropriate empirical antibiotic treatment.
引用
收藏
页码:247 / 257
页数:11
相关论文
共 50 条
  • [1] Clinical predictors and outcomes of Klebsiella pneumoniae bacteraemia in a regional hospital in Hong Kong
    Man, M. Y.
    Shum, H. P.
    Chan, Y. H.
    Chan, K. C.
    Yan, W. W.
    Lee, R. A.
    Lau, S. K. P.
    JOURNAL OF HOSPITAL INFECTION, 2017, 97 (01) : 35 - 41
  • [2] Characteristics and outcomes of Klebsiella pneumoniae bacteraemia in Hong Kong
    Pau, Carrie K. Y.
    Ma, Florence F. T.
    Ip, Margaret
    You, Joyce H. S.
    INFECTIOUS DISEASES, 2015, 47 (05) : 283 - 288
  • [3] Clinical impact of cefepime breakpoint in patients with carbapenem-resistant Klebsiella pneumoniae bacteraemia
    Lee, Nan-Yao
    Lo, Ching-Lung
    Chen, Po-Lin
    Syue, Ling-Shan
    Li, Chia-Wen
    Li, Ming-Chi
    Ko, Wen-Chien
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (02)
  • [4] The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia:: risk factors and outcomes
    Robenshtok, E.
    Paul, M.
    Leibovici, L.
    Fraser, A.
    Pitlik, S.
    Ostfeld, I.
    Samra, Z.
    Perez, S.
    Lev, B.
    Weinberger, M.
    JOURNAL OF HOSPITAL INFECTION, 2006, 64 (03) : 282 - 287
  • [5] Klebsiella pneumoniae bacteraemia in a region of Canada
    Pepin, J.
    Yared, N.
    Alarie, I.
    Lanthier, L.
    Vanasse, A.
    Tessier, P.
    Deveau, J.
    Chagnon, M. -N.
    Comeau, R.
    Cotton, P.
    Libby, S. J.
    Valiquette, L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (02) : 141 - 146
  • [6] Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae bacteraemia in children: a retrospective study
    Meng, Haiyang
    Yang, Jie
    Niu, Mengxia
    Zhu, Han
    Zhou, Yuke
    Lu, Jingli
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (04)
  • [7] Clinical Characteristics and Outcomes of Klebsiella Pneumonia Bacteraemia in Adult
    Lee, T. C.
    Arif, A. Md
    Razali, N. H.
    Kulaisingham, V
    Sukesh, H.
    Tay, V. Y.
    Ghazali, M. A.
    Ewe, J. K.
    Omar, S.
    Othman, H.
    Teck, T. P.
    IIUM MEDICAL JOURNAL MALAYSIA, 2023, 22 (04): : 74 - 81
  • [8] RESISTANCE TO ANTIBIOTICS IN CLINICAL ISOLATES OF KLEBSIELLA-PNEUMONIAE
    OBRIEN, TF
    MAYER, KH
    HOPKINS, JD
    FARRELL, JJ
    CHAO, L
    KENT, RL
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1985, 6 (02): : 64 - 67
  • [9] Mortality risk score for Klebsiella pneumoniae bacteraemia
    Zammit, S. Chetcuti
    Azzopardi, N.
    Sant, J.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (06) : 571 - 576
  • [10] Mortality due to blaKPC Klebsiella pneumoniae bacteraemia
    Fraenkel-Wandel, Yedidah
    Raveh-Brawer, David
    Wiener-Well, Yonit
    Yinnon, Amos M.
    Assous, Marc V.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (04) : 1083 - 1087